Medulloblastoma: genes and variants
Explore variant evidence for Medulloblastoma across 9 analyzed proteins (CTNNB1, SUFU, DDX3X, BRCA2, KMT2C and 4 more). Linked ClinVar records include 4 pathogenic or likely pathogenic variants, 447 variants of uncertain significance and 65 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Medulloblastoma
CTNNB1: Catenin beta-1
It links cadherins to the cytoskeleton at adherens junctions and, when stabilized by Wnt signaling, enters the nucleus to regulate transcription. Activating somatic variants drive many cancers, while germline loss-of-function variants cause CTNNB1 neurodevelopmental disorder.
4 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CTNNB1 have source records linked to Medulloblastoma. Association strength is not clinical gene validity.
SUFU: Suppressor of fused homolog
It restrains GLI transcription factors and thereby keeps Hedgehog signaling off when pathway activation is absent. Germline loss-of-function variants predispose particularly to infant desmoplastic medulloblastoma and can also cause developmental Hedgehog-pathway phenotypes.
0 ClinVar pathogenic / likely pathogenic and 511 uncertain variants in SUFU have source records linked to Medulloblastoma. Association strength is not clinical gene validity.
DDX3X: ATP-dependent RNA helicase DDX3X
An ATP-dependent RNA helicase involved in RNA processing and translation. Pathogenic variants are an established cause of neurodevelopmental disorders, particularly in females.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in DDX3X have source records linked to Medulloblastoma. Association strength is not clinical gene validity.
BRCA2: Breast cancer type 2 susceptibility protein
It loads RAD51 onto damaged DNA to enable homologous recombination and also protects stressed replication forks from degradation. Germline loss-of-function variants strongly predispose to breast, ovarian, prostate, pancreatic, and other cancers.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in BRCA2 have source records linked to Medulloblastoma. Association strength is not clinical gene validity.
KMT2C: Histone-lysine N-methyltransferase 2C
It helps establish enhancer-associated H3K4 methylation and thereby controls lineage-specific transcription together with other COMPASS-family proteins. Somatic loss-of-function alterations are frequent across cancers, while germline variants can cause neurodevelopmental phenotypes.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KMT2C have source records linked to Medulloblastoma. Association strength is not clinical gene validity.
KMT2D: Histone-lysine N-methyltransferase 2D
It deposits enhancer-associated H3K4 methylation and coordinates developmental gene expression through chromatin regulatory complexes. Heterozygous loss-of-function variants are a major cause of Kabuki syndrome, and somatic mutations are common in several lymphomas and solid tumors.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KMT2D have source records linked to Medulloblastoma. Association strength is not clinical gene validity.
PTCH1: Protein patched homolog 1
It suppresses Smoothened in the absence of Hedgehog ligands and thereby keeps Hedgehog developmental signaling inactive until an appropriate signal is received. Germline loss-of-function variants cause Gorlin syndrome, while somatic pathway activation drives basal-cell carcinoma and other tumors.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PTCH1 have source records linked to Medulloblastoma. Association strength is not clinical gene validity.
SMARCA4: SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4
Its ATPase activity drives nucleosome remodeling in BAF-family complexes and thereby controls access to regulatory DNA. Germline pathogenic variants cause Coffin-Siris syndrome or rhabdoid-tumor predisposition, while somatic loss defines several aggressive cancers.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SMARCA4 have source records linked to Medulloblastoma. Association strength is not clinical gene validity.
SMO: Protein smoothened
It transmits Hedgehog signals across the membrane after inhibition by PTCH1 is relieved, activating GLI-dependent developmental transcription. Activating variants or upstream pathway loss can drive basal-cell carcinoma, medulloblastoma, and other Hedgehog-dependent tumors.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SMO have source records linked to Medulloblastoma. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): ARID1A and RB1.
ClinVar pathogenic and likely pathogenic variants linked to Medulloblastoma
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CTNNB1 T41A | 41 | Pathogenic / likely pathogenic (★★) | |
| CTNNB1 D32Y | 32 | Pathogenic / likely pathogenic | |
| CTNNB1 S33F | 33 | Pathogenic / likely pathogenic | |
| CTNNB1 G34E | 34 | Pathogenic / likely pathogenic |
Same protein, different disease
- Pilomatrixoma also has ClinVar records linked to CTNNB1 variants; they fall in the same places as the Medulloblastoma variants (8 pathogenic / likely pathogenic).
- Severe intellectual disability-progressive spastic diplegia syndrome also has ClinVar records linked to CTNNB1 variants; they fall mostly in different places as the Medulloblastoma variants (5 pathogenic / likely pathogenic).
Diseases related to Medulloblastoma
- Ovarian cancer, also linked to BRCA2, CTNNB1 and PTCH1
- Urinary bladder cancer, also linked to CTNNB1, KMT2C and KMT2D
- Gorlin syndrome, also linked to PTCH1 and SUFU
- Ovarian neoplasm, also linked to BRCA2 and CTNNB1
- Basal cell carcinoma, also linked to PTCH1 and SMO
- Basal cell nevus syndrome, also linked to PTCH1 and SUFU
- Head and neck squamous cell carcinoma, also linked to KMT2D and SMARCA4
- Fanconi anemia complementation, also linked to BRCA2
- Kabuki syndrome, also linked to KMT2D
- Acute myeloid leukemia, also linked to SMO
- Hereditary breast cancer, also linked to BRCA2
- Hereditary breast ovarian cancer syndrome, also linked to BRCA2
Frequently asked questions
Which genes have records linked to Medulloblastoma?
This view contains 9 analyzed proteins: CTNNB1, SUFU, DDX3X, BRCA2, KMT2C and 4 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 4 pathogenic or likely pathogenic variants, 447 variants of uncertain significance and 65 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 543 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center